Gni Group Ltd. (2160) Press Release
Notice Concerning Filing of Form S-3 Registration Statement by Gyre Therapeutics
Earlier from Gni
- GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
- Transformational Acquisition of Ayumi Pharmaceutical Holdings
- GNI: Financial Results Briefing for Q2 FY 2025 (on August 29, 2025)
- GNI: FY2023Q1 Earnings Call Transcript